Is filgrastim as useless after peripheral blood stem cell transplantation for adults as it could be for children?
暂无分享,去创建一个
F. Hernández-Navarro | E. Quevedo | E. Ojeda | R. Arrieta | J. Garcia-Bustos | M. Canales | M. J. Agaudo | V. Jimenez
[1] E. Ito,et al. Marginal benefit/disadvantage of granulocyte colony-stimulating factor therapy after autologous blood stem cell transplantation in children: results of a prospective randomized trial. The Japanese Cooperative Study Group of PBSCT. , 1998, Blood.
[2] S. Kudoh,et al. Pulmonary toxicity after granulocyte colony-stimulating factor-combined chemotherapy for non-Hodgkin's lymphoma. , 1998, British Journal of Cancer.
[3] J. Vose,et al. A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantation. , 1998, Blood.
[4] D. Blaise,et al. Administration of G-CSF can be delayed after transplantation of autologous G-CSF-primed blood stem cells: a randomized study. , 1996, Bone marrow transplantation.
[5] R. Storb,et al. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.